Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review.

While DMT use (versus no use) was not associated with gut microbiota diversity differences, taxa-level differences were observed. Further work is warranted, as most studies were cross-sectional, few examined functionality, and DMTs were combined.